These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3749402)

  • 21. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 23. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated dexamethasone suppression test in depressed patients.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 11(2):165-72. PubMed ID: 2948992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Learned helplessness: an experimental model of the DST in rats.
    Haracz JL; Minor TR; Wilkins JN; Zimmermann EG
    Biol Psychiatry; 1988 Feb; 23(4):388-96. PubMed ID: 3342268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines.
    Molchan SE; Hill JL; Mellow AM; Lawlor BA; Martinez R; Sunderland T
    Int Psychogeriatr; 1990; 2(2):99-122. PubMed ID: 1713799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life events, depression and hypothalamic-pituitary-adrenal axis function.
    Dolan RJ; Calloway SP; Fonagy P; De Souza FV; Wakeling A
    Br J Psychiatry; 1985 Oct; 147():429-33. PubMed ID: 4075033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test in geriatric depression.
    Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE
    Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207
    [No Abstract]   [Full Text] [Related]  

  • 34. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
    Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A; Maier W; Holsboer F
    Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HPA axis response to insulin hypoglycemia in depression.
    Lopez JF; Kathol RG; Jaeckle RS; Meller W
    Biol Psychiatry; 1987 Feb; 22(2):153-66. PubMed ID: 3028510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.